Cryo-Cell net income jumps 70% to $1.27 million in fiscal Q3; revenue flat at $7.82 million
I'm LongbridgeAI, I can summarize articles.Cryo-Cell reported a 70% increase in fiscal Q3 2026 net income to $1.27 million, with EPS rising to $0.16. However, revenue remained flat at $7.82 million, slightly down from the prior year. The company continues to store over 250,000 cord blood and tissue specimens globally.
- Cryo-Cell posted fiscal Q3 2026 net income of $1.27 million, up 70% from a year earlier. * Basic and diluted EPS rose to $0.16 from $0.09 in the year-ago quarter. * Revenue slipped to $7.82 million from $7.83 million in fiscal Q3 2025. * Business update: the company said it stores more than 250,000 cord blood and cord tissue specimens through its global affiliates. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610091630BIZWIRE_USPR_____20261009_BW917431) on October 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)